Dr
Daniel
Woollaston

Patent Director

Leeds Office York Office

Chemistry

Telephone. +44(0) 113 233 0100
Mobile. +44(0) 738 487 7685
Email. [email protected]

Experience

Since joining HGF in 2010, much of Daniel’s work has concerned the drafting and prosecuting of patent applications across a broad spectrum of chemical sciences, but particularly in the fields of pharmaceuticals, medicinal chemistry, organic chemistry, graphene and other 2D materials, chemical engineering, carbon capture, dyes, agrochemicals, and resins for use in 3D printers. Daniel also has experience in advising on freedom to operate issues.

Daniel has formulated complex IP strategies for several award winning UK pharmaceutical companies.

He has worked extensively with a number of UK Russell Group universities for whom he has provided patentability opinions and drafted and prosecuted to grant worldwide patent applications in a range of technically complex chemistry related subject matters.

Specialisms

  • Pharmaceutical technologies

Industries

  • Agrochemicals icon Agrochemicals
  • CleanTech icon CleanTech
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Due diligence
  • Patent term extensions & SPCs
  • Patents
  • Portfolio management
  • Strategy

Qualifications

Patent Attorney

Chartered (UK)
European


MCHEM

University of Oxford

PHD

Organic Chemistry; University of Oxford

Conferences: 2021

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Related News

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article

Getting your first filing right

One of the most often asked questions of patent attorneys is “when should we file?” Both timing and content of a first filing should be important strategic decisions. This is …

Read article

Tarilian Laser Technologies - a case study in due diligence

When deciding whether to invest in a company, an investor will inevitably have to decide the value of the company. Taking a simplified view, a company’s valuation can be considered …

Read article

Health-conscious IP strategies

Strategies for navigating European patent portfolios in healthcare. Securing patent protection is critically important for innovative companies operating in the healthcare sector. European patent filings in healthcare, and particularly those …

Read article

Start-ups & IP, a case study: SleepCogni

Using SleepCogni as a case study, we look at some key ways that IP can help start-ups to develop their technology and secure investment. SleepCogni is a SleepTech start-up who …

Read article
Event - 9th December 2021

Technology Transfer Primer - IP Management: AI and 5G in healthcare

The University of Hong Kong is hosting a webinar on ‘IP Management: AI and 5G in healthcare’ on 9th December 2021 with HGF’s Partner Dr Chris Benson and Patent Director …

Event details
Event - 1st December 2021

Webinar: Patent eligibility of AI-related pharmaceutical inventions and practical tips for its patent obtainment in Japan

Join our webinar on 1st December, where speakers from Shiga, one of the leading IP firms in Japan, will present on ‘Patent eligibility of AI-related pharmaceutical inventions and practical tips …

Event details

Lab-grown meat – not yet on the menu

It is now eight years since the first lab-grown burger was unveiled by a team of scientists at Maastricht University, but since then the path to market has been slow. …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.